Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,058
Closed -$158K 775
2022
Q2
$158K Hold
11,058
﹤0.01% 792
2022
Q1
$206K Hold
11,058
﹤0.01% 807
2021
Q4
$233K Sell
11,058
-7,168
-39% -$142K ﹤0.01% 747
2021
Q3
$398K Buy
18,226
+702
+4% +$16.2K 0.01% 618
2021
Q2
$418K Buy
17,524
+1,058
+6% +$21.1K 0.01% 570
2021
Q1
$234K Buy
+16,466
New +$181K ﹤0.01% 692

Other funds holding BAK

Colony Group's BAK Position: Q3 2022 in Review

Colony Group sold out of Braskem (BAK) in Q3 2022, closing a stake of 11,058 shares — an estimated $158K sold.

Colony Group first reported a position in BAK in Q1 2021 and held it in 6 quarters. The position peaked at $418K in Q2 2021. 45 funds tracked by Wall St. Rank hold BAK as of Q3 2022.

  • Colony Group reported no remaining Braskem position as of Q3 2022 after selling out during the quarter.
  • Colony Group sold 11,058 Braskem shares in Q3 2022, an estimated $158K.
  • Colony Group first reported a position in Braskem in Q1 2021 and held it in 6 quarters.
  • Colony Group's Braskem position peaked at $418K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Braskem as of Q3 2022.

Based on Colony Group's 13F filing for Q3 2022, filed 15 Nov 2022.